Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer Meeting Abstract


Authors: Lyons, T.; Gucalp, A.; Arumov, A.; Patil, S.; Edelweiss, M.; Gorsky, M.; Troso-Sandoval, T. A.; Bromberg, J.; Sanford, R. A.; Iyengar, N. M.; Modi, S.; Gupta, R.; Traina, T. A.
Abstract Title: Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 16s
Language: English
ACCESSION: WOS:000442916000041
DOI: 10.1200/JCO.2018.36.15_suppl.531
PROVIDER: wos
Notes: Meeting Abstract: 531 -- Source: Wos
Altmetric Score
MSK Authors
  1. Sujata Patil
    365 Patil
  2. Mila Gorsky
    5 Gorsky
  3. Jacqueline Bromberg
    103 Bromberg
  4. Ayca Gucalp
    77 Gucalp
  5. Tiffany A Traina
    145 Traina
  6. Shanu Modi
    128 Modi
  7. Neil Mukund Iyengar
    62 Iyengar
  8. Tomas Gerard Lyons
    6 Lyons
  9. Artavazd Arumov
    2 Arumov